Weight-loss drug Zepbound helped drive Ireland to $76 billion in goods exports to the U.S. last year—a bittersweet reminder of the challenges ahead
Ireland's pharmaceutical industry shipped billions' worth of goods to the U.S., but face threats from Trump 2.0.
Irish Examiner4d
What inspires American companies to choose to locate in Ireland?
Colm Greaves, a former tech sector executive and now a full-time journalist, revisits an MBA exam question that he faced some ...
pharmaphorum1d
Clinical trends for 2025: A year of change
3 Big news is also expected from some of the major players; for example, Eli Lilly is aiming to conclude ... Stefano Gullà, CSO at Kling Bio, added that, although infectious diseases investment ...
Hosted on MSN1d
EU and Irish Gov must act to protect Cork's crucial pharma sector from Trump Tariffs
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...
Eli Lilly aims to invest in ‘big problems hiding in plain sight' using obesity windfall
Eli Lilly wants to take big swings in Alzheimer’s, ALS, chronic pain and other difficult diseases after its success in ...
From pills to new uses, here's what Eli Lilly's top scientist sees as the future of weight loss drugs
Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.
The Motley Fool5d
Think Eli Lilly's Stock Is Expensive? Here's Why Selling It Now Could Be a Huge Mistake
For years, Eli Lilly has been generating solid growth numbers -- but lately, they've been accelerating rapidly. The company is coming off a solid quarter where its revenue rose by 45% for the last ...
Myris Therapeutics is Developing Ultra-High DAR ADCs to Enable Novel Precision Medicine Treatments for Cancer
Myris Therapeutics™ emerged from stealth today to announce its strategic focus. Myris, formerly known as BioHybrid Solutions, ...